Intas is Officially a "Great Place to Work" Certified
This certification highlights our shared dedication to creating supportive, inclusive and engaging workspace.
A Global Healthcare Partner
Intas is trusted by healthcare professionals across more than 85 countries across the globe
A Dynamic Product Basket
Empowered by a passionate R&D Team, Intas has one of the strongest product portfolios in the world
Plasma Therapy for Life
>Click Here to know more about India’s Leading Plasma Fractionation Centre
Intas Pharmaceuticals Ltd.
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at ~22% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness and hope.
Read MoreExcellence is a Matter of Fact
Transforming Science into Smiles
R & D is at the heart of Intas’ success. A highly qualified team works round the clock with a quest to develop a progressive threefold product basket that includes world-class generics, oncology and parenteral as well as added-value products (AVPs).
- 6-7% of turnover invested in R & D, year on year
- Over 1,00,000 sq ft dedicated R&D space
- 550+ Scientists and Researchers
- 17 Advanced Facilities
- Global Regulatory Authority Accreditations
- Pioneer in Biosimilars
Latest News
INTAS launches THYMOTAS - a patented, powerful immuno-booster add-on to standard COVID-19 treatment
Intas Pharmaceuticals becomes the first to launch Romiplostim in India, revolutionizing chronic immune thrombocytopenia (ITP) therapy.
